The Capital Group Companies, Inc. - Net Worth and Insider Trading
The Capital Group Companies, Inc. Net Worth
The estimated net worth of The Capital Group Companies, Inc. is at least $6.1 Billion dollars as of 2025-06-06. The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of WuXi Biologics (Cayman) Inc and owns about 246,875,619 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) stock worth over $6.1 Billion. Details can be seen in The Capital Group Companies, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that The Capital Group Companies, Inc. has not made any transactions after 2022-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, The Capital Group Companies, Inc. owns 1 companies in total, including WuXi Biologics (Cayman) Inc (HKSE:02269) .
Insider Ownership Summary of The Capital Group Companies, Inc.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02269 | WuXi Biologics (Cayman) Inc | 2022-10-27 | 2201 Interest of corporation controlled by you |
The Capital Group Companies, Inc. Latest Holdings Summary
The Capital Group Companies, Inc. currently owns a total of 1 stock. The Capital Group Companies, Inc. owns 246,875,619 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) as of October 27, 2022, with a value of $6.1 Billion.
Latest Holdings of The Capital Group Companies, Inc.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02269 | WuXi Biologics (Cayman) Inc | 2022-10-27 | 246,875,619 | 24.65 | 6,085,484,008 |
Holding Weightings of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, The Capital Group Companies, Inc. has made a total of 3 transactions in WuXi Biologics (Cayman) Inc (HKSE:02269) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in WuXi Biologics (Cayman) Inc is the sale of 26,652,272 shares on October 27, 2022, which brought The Capital Group Companies, Inc. around $1.1 Billion.
Insider Trading History of The Capital Group Companies, Inc.
- 1
The Capital Group Companies, Inc. Trading Performance
GuruFocus tracks the stock performance after each of The Capital Group Companies, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by The Capital Group Companies, Inc. is -6.19%. GuruFocus also compares The Capital Group Companies, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by The Capital Group Companies, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how The Capital Group Companies, Inc.'s insider trading performs compared to the benchmark.
Performance of The Capital Group Companies, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.52 | | | | | |
| Relative Return to S&P 500(%) | 15.47 | | | | | |
The Capital Group Companies, Inc. Ownership Network
Ownership Network List of The Capital Group Companies, Inc.
Ownership Network Relation of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Owned Company Details
What does WuXi Biologics (Cayman) Inc do?
Who are the key executives at WuXi Biologics (Cayman) Inc?
The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of WuXi Biologics (Cayman) Inc. Other key executives at WuXi Biologics (Cayman) Inc include 2201 Interest of corporation controlled by you BlackRock, Inc. , 2201 Interest of corporation controlled by you Li Ge , and 2401 A concert party to an agreement to buy shares Liu Xiaozhong .
WuXi Biologics (Cayman) Inc (HKSE:02269) Insider Trades Summary
Over the past 18 months, The Capital Group Companies, Inc. made no insider transaction in WuXi Biologics (Cayman) Inc (HKSE:02269). Other recent insider transactions involving WuXi Biologics (Cayman) Inc (HKSE:02269) include a net purchase of 82,515,505 shares made by Jpmorgan Chase & Co. , a net sale of 0 shares made by BlackRock, Inc. , and a net sale of 0 shares made by Citigroup Inc. .
In summary, during the past 3 months, insiders sold 0 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,955,867 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) were sold and 136,982,872 shares were bought by its insiders, resulting in a net purchase of 90,027,005 shares.
WuXi Biologics (Cayman) Inc (HKSE:02269)'s detailed insider trading history can be found in Insider Trading Tracker table.
WuXi Biologics (Cayman) Inc Insider Transactions
The Capital Group Companies, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for The Capital Group Companies, Inc.. Currently GuruFocus does not have mailing address information for The Capital Group Companies, Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
